title: MG132 treated cells
organism: Homo sapiens
description: Protocols: DMEM (15% FBS, 1% glutamin) medium, 37°C, 5% CO2 HGPS fibroblasts treated with DMSO (vehicle control) or with MG132 for 6 hours rneasy mini kit TruSeq Stranded mRNA
attributes.tag: ENA first public
attributes.value: 2017-06-18
attributes.tag: ENA last update
attributes.value: 2017-06-08
attributes.tag: External Id
attributes.value: SAMEA104116684
attributes.tag: INSDC center alias
attributes.value: INSERM U910 Marseille
attributes.tag: INSDC center name
attributes.value: INSERM U910 Marseille
attributes.tag: INSDC first public
attributes.value: 2017-06-18T17:01:24Z
attributes.tag: INSDC last update
attributes.value: 2017-06-08T10:35:36Z
attributes.tag: INSDC status
attributes.value: public
attributes.tag: Submitter Id
attributes.value: E-MTAB-5807:MG132 treated cells
attributes.tag: broker name
attributes.value: ArrayExpress
attributes.tag: cell line
attributes.value: fibroblast derived cell line
attributes.tag: common name
attributes.value: human
attributes.tag: disease
attributes.value: Hutchinson-Gilford progeria syndrome
attributes.tag: sample name
attributes.value: E-MTAB-5807:MG132 treated cells
attributes.tag: sex
attributes.value: male